Alnylam Pharmaceuticals Cvt
-
$160,000
0.0% of portfolio
-
Q1 2025
New
$48.5B
$37,000
0.0% of portfolio
163
Q1 2025
Reduced 35.57%
$48.3B
$105,000
0.0% of portfolio
540
Q1 2025
Added 7.36%
-
$103,000
0.0% of portfolio
-
Q4 2024
Reduced 54.54%
Lantheus Holdings Inc Cvt
-
$245,000
0.0% of portfolio
-
Q4 2024
New
$132B
$58,000
0.0% of portfolio
247
Q1 2025
Reduced 35.0%
$19.4B
$104,000
0.0% of portfolio
1,471
Q1 2025
Added 98.25%
$30.8B
$86,000
0.0% of portfolio
481
Q1 2025
Added 75.55%
$1.34B
$27,000
0.0% of portfolio
871
Q1 2025
Reduced 41.5%
$258B
$102,000
0.0% of portfolio
510
Q1 2025
Reduced 26.41%
$31.5B
$152,000
0.0% of portfolio
2,539
Q1 2025
Added 21.77%
$83.1B
$46,000
0.0% of portfolio
192
Q1 2025
Reduced 35.14%
$59.7B
$43,000
0.0% of portfolio
696
Q3 2024
Reduced 29.05%
$135B
$48,000
0.0% of portfolio
424
Q1 2025
Reduced 34.97%
$574M
$8,000
0.0% of portfolio
503
Q1 2025
New
$1.23B
$405,000
0.0% of portfolio
15,186
Q1 2025
Reduced 93.53%
$20.4B
$114,000
0.0% of portfolio
845
Q1 2025
Reduced 93.79%
$26.7B
$45,000
0.0% of portfolio
391
Q1 2025
Reduced 35.05%
-
$35,000
0.0% of portfolio
-
Q1 2025
Reduced 6.11%
-
$22,000
0.0% of portfolio
-
Q1 2025
Reduced 99.82%
-
$40,000
0.0% of portfolio
-
Q1 2025
New
Halozyme Therapeutics In Cvt
-
$228,000
0.0% of portfolio
-
Q1 2025
New
-
$1,000
0.0% of portfolio
-
Q1 2025
Reduced 15.91%
$0
$1.63 Million
0.0% of portfolio
140,000
Q1 2025
New
$77.2B
$11,000
0.0% of portfolio
41
Q1 2025
Reduced 36.92%
$5.36B
$86,000
0.0% of portfolio
3,393
Q1 2025
New
$215B
$405,000
0.0% of portfolio
1,296
Q1 2025
Added 40.56%
$90.9B
$172,000
0.0% of portfolio
2,532
Q1 2025
Added 75.96%
-
$217,000
0.0% of portfolio
-
Q1 2025
Reduced 98.96%
$86.3B
$2.62 Million
0.0% of portfolio
5,620
Q1 2025
Added 110.09%
$6.48B
$30,000
0.0% of portfolio
547
Q1 2025
New
$12.8B
$744,000
0.0% of portfolio
2,482
Q1 2025
Reduced 0.04%
$2.56B
$14,000
0.0% of portfolio
1,431
Q1 2025
New
$26.2B
$81,000
0.0% of portfolio
2,071
Q1 2025
Added 97.99%
$3.12B
$30,000
0.0% of portfolio
411
Q1 2025
Reduced 35.68%
$12.7B
$54,000
0.0% of portfolio
223
Q1 2025
Added 19.89%
$79.5B
$46,000
0.0% of portfolio
209
Q1 2025
Reduced 35.49%
-
$6,000
0.0% of portfolio
-
Q1 2025
New
$115B
$233,000
0.0% of portfolio
2,588
Q1 2025
Added 36.21%
$37.9B
$79,000
0.0% of portfolio
366
Q1 2025
Reduced 19.74%
$0
$73,000
0.0% of portfolio
1,988
Q1 2025
New
$81.1B
$713,000
0.0% of portfolio
7,409
Q1 2025
Added 4.56%
$62.1B
$136,000
0.0% of portfolio
1,700
Q1 2025
Added 26.77%
-
$1.08 Million
0.0% of portfolio
-
Q1 2025
Added 3.27%
$101B
$45,000
0.0% of portfolio
259
Q1 2025
Reduced 35.09%
$7.22B
$347,000
0.0% of portfolio
9,692
Q1 2025
Reduced 90.86%
$7.44B
$31,000
0.0% of portfolio
737
Q1 2025
Reduced 44.29%
$21.1B
$84,000
0.0% of portfolio
318
Q1 2025
New
$205M
$2.4 Million
0.0% of portfolio
1,457,160
Q1 2025
Reduced 0.69%
$0
$2.1 Million
0.0% of portfolio
56,500
Q1 2025
New